Chromosome 13


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching   

ENTITIES: by Chromosome band

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Chromosome 13


[previous]   13 13p 13q 13p13 13p12 13p11 13q11 13q12 13q13 13q14 13q21 13q22 13q31 13q32 13q33 13q34   [next]

chr13:0-114364328 (114364.328 Kb)

Abnormalities in chromosome 13

(click on headers to reorder columns)
Band 1Band 2ClassEntityPartner 1Partner 2LinksTopographyMorphology[PubMed][Study]
13 Mitelman-13  Mitelman (CGAP) Acute basophilic leukemia  
13 Mitelman-13  Mitelman (CGAP) Acute erythroleukemia (FAB type M6)  
13 Mitelman+13  Mitelman (CGAP) Acute erythroleukemia (FAB type M6)  
13 Mitelman+13  Mitelman (CGAP) Acute lymphoblastic leukemia/lymphoblastic lymphoma  
13 Mitelman-13  Mitelman (CGAP) Acute lymphoblastic leukemia/lymphoblastic lymphoma[PubMed] 
13 Mitelman-13  Mitelman (CGAP) Acute megakaryoblastic leukemia (FAB type M7)  
13 Mitelman+13  Mitelman (CGAP) Acute megakaryoblastic leukemia (FAB type M7)  
13 Mitelman-13  Mitelman (CGAP) Acute monoblastic leukemia (FAB type M5)  
13 Mitelman+13  Mitelman (CGAP) Acute monoblastic leukemia (FAB type M5)  
13 Mitelman-13  Mitelman (CGAP) Acute monoblastic leukemia with differentiation (FAB type M5b)  
13 Mitelman+13  Mitelman (CGAP) Acute monoblastic leukemia with differentiation (FAB type M5b)  
13 Mitelman-13  Mitelman (CGAP) Acute monoblastic leukemia without differentiation (FAB type M5a)  
13 Mitelman+13  Mitelman (CGAP) Acute monoblastic leukemia without differentiation (FAB type M5a)  
13 Mitelman-13  Mitelman (CGAP) Acute myeloblastic leukemia with maturation (FAB type M2)  
13 Mitelman+13  Mitelman (CGAP) Acute myeloblastic leukemia with maturation (FAB type M2)  
13 Mitelman-13  Mitelman (CGAP) Acute myeloblastic leukemia with minimal differentiation (FAB type M0)  
13 Mitelman+13  Mitelman (CGAP) Acute myeloblastic leukemia with minimal differentiation (FAB type M0)[PubMed] 
13 Mitelman-13  Mitelman (CGAP) Acute myeloblastic leukemia without maturation (FAB type M1)  
13 Mitelman+13  Mitelman (CGAP) Acute myeloblastic leukemia without maturation (FAB type M1)  
13 Mitelman+13  Mitelman (CGAP) Acute myeloid leukemia, NOS[PubMed] 
13 Mitelman-13  Mitelman (CGAP) Acute myeloid leukemia, NOS[PubMed] 
13 Mitelman+13  Mitelman (CGAP) Acute myeloid leukemia, special type  
13 Mitelman-13  Mitelman (CGAP) Acute myelomonocytic leukemia (FAB type M4)  
13 Mitelman+13  Mitelman (CGAP) Acute myelomonocytic leukemia (FAB type M4)  
13 Mitelman-13  Mitelman (CGAP) Acute promyelocytic leukemia (FAB type M3)  
13 Mitelman+13  Mitelman (CGAP) Acute promyelocytic leukemia (FAB type M3)  
13 Mitelman+13  Mitelman (CGAP) Acute undifferentiated leukemia[PubMed] 
13 Mitelman-13  Mitelman (CGAP) Adenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)AdrenalNeuroblastoma  
13 Mitelman+13  Mitelman (CGAP)AdrenalNeuroblastoma  
13 Mitelman-13  Mitelman (CGAP) Adult T-cell lymphoma/leukemia (HTLV-1+)  
13 Mitelman+13  Mitelman (CGAP) Adult T-cell lymphoma/leukemia (HTLV-1+)  
13 Mitelman-13  Mitelman (CGAP) Aggressive NK-cell leukemia  
13 Mitelman+13  Mitelman (CGAP) Aggressive NK-cell leukemia  
13 Mitelman-13  Mitelman (CGAP) Anaplastic large cell lymphoma, systemic type  
13 Mitelman-13  Mitelman (CGAP)AnusSquamous cell carcinoma  
13 Mitelman+13  Mitelman (CGAP) Atypical chronic myeloid leukemia  
13 Mitelman-13  Mitelman (CGAP) Bilineage or biphenotypic leukemia  
13 Mitelman+13  Mitelman (CGAP) Bilineage or biphenotypic leukemia  
13 Mitelman+13  Mitelman (CGAP)BladderEmbryonal rhabdomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)BladderSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)BladderTransitional cell carcinoma  
13 Mitelman+13  Mitelman (CGAP)BladderTransitional cell carcinoma  
13 Mitelman-13  Mitelman (CGAP) B-prolymphocytic leukemia  
13 Mitelman-13  Mitelman (CGAP)BrainAstrocytoma, grade III-IV/Glioblastoma  
13 Mitelman+13  Mitelman (CGAP)BrainAstrocytoma, grade III-IV/Glioblastoma  
13 Mitelman-13  Mitelman (CGAP)BrainAstrocytoma, NOS  
13 Mitelman-13  Mitelman (CGAP)BrainAstrocytoma, pilocytic/juvenile  
13 Mitelman+13  Mitelman (CGAP)BrainAstrocytoma, pilocytic/juvenile  
13 Mitelman-13  Mitelman (CGAP)BrainChoroid plexus papilloma/carcinoma  
13 Mitelman+13  Mitelman (CGAP)BrainChoroid plexus papilloma/carcinoma  
13 Mitelman-13  Mitelman (CGAP)BrainEpendymoma  
13 Mitelman+13  Mitelman (CGAP)BrainEpendymoma  
13 Mitelman-13  Mitelman (CGAP)BrainGerm cell tumor, NOS  
13 Mitelman-13  Mitelman (CGAP)BrainGlioma, NOS  
13 Mitelman-13  Mitelman (CGAP)BrainMeningioma  
13 Mitelman+13  Mitelman (CGAP)BrainMeningioma  
13 Mitelman-13  Mitelman (CGAP)BrainNeuroglial neoplasm, special type  
13 Mitelman-13  Mitelman (CGAP)BrainPrimitive neuroectodermal tumor/Medulloblastoma  
13 Mitelman+13  Mitelman (CGAP)BrainPrimitive neuroectodermal tumor/Medulloblastoma  
13 Mitelman-13  Mitelman (CGAP)Brain stemAstrocytoma, grade I-II  
13 Mitelman-13  Mitelman (CGAP)Brain stemAstrocytoma, grade III-IV/Glioblastoma  
13 Mitelman+13  Mitelman (CGAP)Brain stemEpendymoma  
13 Mitelman-13  Mitelman (CGAP)BreastAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)BreastAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)BreastBenign epithelial tumor, NOS  
13 Mitelman+13  Mitelman (CGAP)BreastBenign epithelial tumor, NOS  
13 Mitelman+13  Mitelman (CGAP)BreastBenign epithelial tumor, special type  
13 Mitelman-13  Mitelman (CGAP)BreastCarcinoma in situ  
13 Mitelman-13  Mitelman (CGAP)BreastCarcinoma, NOS  
13 Mitelman+13  Mitelman (CGAP)BreastCarcinoma, NOS  
13 Mitelman-13  Mitelman (CGAP)BreastHyperplasia  
13 Mitelman+13  Mitelman (CGAP)BreastHyperplasia  
13 Mitelman-13  Mitelman (CGAP)BreastMalignant epithelial tumor, special type  
13 Mitelman+13  Mitelman (CGAP)BreastNonneoplastic epithelial disorder/lesion  
13 Mitelman-13  Mitelman (CGAP) Burkitt lymphoma/leukemia  
13 Mitelman+13  Mitelman (CGAP) Burkitt lymphoma/leukemia  
13 Mitelman-13  Mitelman (CGAP)CerebellumEpendymoma  
13 Mitelman+13  Mitelman (CGAP)CerebellumEpendymoma  
13 Mitelman-13  Mitelman (CGAP)CerebellumPrimitive neuroectodermal tumor/Medulloblastoma  
13 Mitelman+13  Mitelman (CGAP)CerebellumPrimitive neuroectodermal tumor/Medulloblastoma  
13 Mitelman-13  Mitelman (CGAP) Chronic eosinophilic leukemia/hypereosinophilic syndrome  
13 Mitelman-13  Mitelman (CGAP) Chronic lymphocytic leukemia  
13 Mitelman+13  Mitelman (CGAP) Chronic lymphocytic leukemia  
13 Mitelman+13  Mitelman (CGAP) Chronic myeloid leukemia, aberrant translocation  
13 Mitelman-13  Mitelman (CGAP) Chronic myeloid leukemia, t(9;22)  
13 Mitelman+13  Mitelman (CGAP) Chronic myeloid leukemia, t(9;22)  
13 Mitelman-13  Mitelman (CGAP) Chronic myelomonocytic leukemia  
13 Mitelman+13  Mitelman (CGAP) Chronic myelomonocytic leukemia  
13 Mitelman+13  Mitelman (CGAP) Chronic myeloproliferative disorder, NOS  
13 Mitelman-13  Mitelman (CGAP) Dendritic cell neoplasm  
13 Mitelman-13  Mitelman (CGAP) Diffuse large B-cell lymphoma  
13 Mitelman+13  Mitelman (CGAP) Diffuse large B-cell lymphoma  
13 Mitelman-13  Mitelman (CGAP) Embryonal nervous system tumor, special type  
13 Mitelman+13  Mitelman (CGAP) Essential thrombocythemia  
13 Mitelman-13  Mitelman (CGAP) Extranodal NK/T-cell lymphoma  
13 Mitelman-13  Mitelman (CGAP)EyeMalignant melanoma  
13 Mitelman+13  Mitelman (CGAP)EyeMalignant melanoma  
13 Mitelman-13  Mitelman (CGAP)EyeRetinoblastoma  
13 Mitelman+13  Mitelman (CGAP)EyeRetinoblastoma  
13 Mitelman-13  Mitelman (CGAP) Follicular lymphoma  
13 Mitelman+13  Mitelman (CGAP) Follicular lymphoma  
13 Mitelman-13  Mitelman (CGAP)Gallbladder/Biliary systemAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)Gallbladder/Biliary systemAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP) Hairy cell leukemia  
13 Mitelman-13  Mitelman (CGAP) Hodgkin disease, lymphocyte depletion  
13 Mitelman-13  Mitelman (CGAP) Hodgkin disease, lymphocyte predominance  
13 Mitelman-13  Mitelman (CGAP) Hodgkin disease, mixed cellularity  
13 Mitelman-13  Mitelman (CGAP) Hodgkin disease, nodular sclerosis  
13 Mitelman-13  Mitelman (CGAP) Hodgkin disease, NOS  
13 Mitelman-13  Mitelman (CGAP) Idiopathic myelofibrosis  
13 Mitelman+13  Mitelman (CGAP) Idiopathic myelofibrosis  
13 Mitelman-13  Mitelman (CGAP)IntraabdominalAlveolar rhabdomyosarcoma  
13 Mitelman+13  Mitelman (CGAP)IntraabdominalEmbryonal rhabdomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)IntraabdominalGastrointestinal stromal tumor  
13 Mitelman-13  Mitelman (CGAP)IntraabdominalLeiomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)IntraabdominalLiposarcoma, pleomorphic  
13 Mitelman-13  Mitelman (CGAP)IntraabdominalMalignant peripheral nerve sheath tumor/Triton  
13 Mitelman-13  Mitelman (CGAP)IntraabdominalNeuroblastoma  
13 Mitelman+13  Mitelman (CGAP)IntraabdominalNeuroblastoma  
13 Mitelman-13  Mitelman (CGAP)IntrathoracalCombined germ cell tumors  
13 Mitelman+13  Mitelman (CGAP)IntrathoracalMalignant peripheral nerve sheath tumor/Triton  
13 Mitelman-13  Mitelman (CGAP)IntrathoracalSeminoma/Dysgerminoma  
13 Mitelman-13  Mitelman (CGAP)IntrathoracalTeratoma (mature and immature)  
13 Mitelman+13  Mitelman (CGAP) Juvenile myelomonocytic leukemia  
13 Mitelman-13  Mitelman (CGAP)KidneyAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)KidneyAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)KidneyBenign epithelial tumor, special type  
13 Mitelman+13  Mitelman (CGAP)KidneyBenign epithelial tumor, special type  
13 Mitelman-13  Mitelman (CGAP)KidneyMalignant epithelial tumor, special type  
13 Mitelman-13  Mitelman (CGAP)KidneyOncocytoma  
13 Mitelman-13  Mitelman (CGAP)KidneyWilms tumor  
13 Mitelman+13  Mitelman (CGAP)KidneyWilms tumor  
13 Mitelman-13  Mitelman (CGAP)Large intestineAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)Large intestineAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)Large intestineAdenoma  
13 Mitelman+13  Mitelman (CGAP)Large intestineCarcinoma in situ  
13 Mitelman-13  Mitelman (CGAP)Large intestineCarcinoma, NOS  
13 Mitelman+13  Mitelman (CGAP)Large intestineCarcinoma, NOS  
13 Mitelman-13  Mitelman (CGAP)LarynxSquamous cell carcinoma  
13 Mitelman+13  Mitelman (CGAP)LarynxSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)LiverAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)LiverAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)LiverHepatoblastoma  
13 Mitelman+13  Mitelman (CGAP)LiverHepatoblastoma  
13 Mitelman-13  Mitelman (CGAP)LungAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)LungAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)LungAdenosquamous carcinoma  
13 Mitelman+13  Mitelman (CGAP)LungMesenchymal tumor, special type  
13 Mitelman-13  Mitelman (CGAP)LungMuscle tumor, special type  
13 Mitelman-13  Mitelman (CGAP)LungSquamous cell carcinoma  
13 Mitelman+13  Mitelman (CGAP)LungSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)LungUndifferentiated carcinoma  
13 Mitelman-13  Mitelman (CGAP)LungUndifferentiated carcinoma, large cell  
13 Mitelman-13  Mitelman (CGAP)LungUndifferentiated carcinoma, small cell  
13 Mitelman+13  Mitelman (CGAP) Mantle cell lymphoma  
13 Mitelman-13  Mitelman (CGAP) Mantle cell lymphoma[PubMed] 
13 Mitelman-13  Mitelman (CGAP) Mature B-cell neoplasm, NOS  
13 Mitelman+13  Mitelman (CGAP) Mature B-cell neoplasm, NOS  
13 Mitelman-13  Mitelman (CGAP) Mature T- and NK-cell neoplasm, NOS[PubMed] 
13 Mitelman+13  Mitelman (CGAP) Multiple myeloma  
13 Mitelman-13  Mitelman (CGAP) Multiple myeloma[PubMed] 
13 Mitelman-13  Mitelman (CGAP) Mycosis fungoides/Szary syndrome  
13 Mitelman+13  Mitelman (CGAP) Myelodysplastic/myeloproliferative disease, NOS  
13 Mitelman-13  Mitelman (CGAP) Myelodysplastic syndrome, NOS  
13 Mitelman+13  Mitelman (CGAP) Myelodysplastic syndrome, NOS  
13 Mitelman-13  Mitelman (CGAP)NasopharynxSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP) Nodal marginal zone B-cell lymphoma  
13 Mitelman+13  Mitelman (CGAP) Nodal marginal zone B-cell lymphoma  
13 Mitelman-13  Mitelman (CGAP)OesophagusAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)OesophagusAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)OesophagusSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)Oral cavitySquamous cell carcinoma  
13 Mitelman+13  Mitelman (CGAP)Oral cavitySquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)Oro- and hypopharynxSquamous cell carcinoma  
13 Mitelman+13  Mitelman (CGAP)Oro- and hypopharynxSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)OvaryAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)OvaryAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)OvaryAdenoma  
13 Mitelman-13  Mitelman (CGAP)OvaryCombined germ cell tumors  
13 Mitelman+13  Mitelman (CGAP)OvaryFibroma  
13 Mitelman-13  Mitelman (CGAP)OvaryMalignant epithelial tumor, special type  
13 Mitelman-13  Mitelman (CGAP)OvaryTeratoma (mature and immature)  
13 Mitelman+13  Mitelman (CGAP)OvaryTeratoma (mature and immature)  
13 Mitelman-13  Mitelman (CGAP)OvaryUndifferentiated carcinoma  
13 Mitelman-13  Mitelman (CGAP)PancreasAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)PancreasAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)PenisSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP) Peripheral T-cell lymphoma, unspecified  
13 Mitelman+13  Mitelman (CGAP) Peripheral T-cell lymphoma, unspecified  
13 Mitelman-13  Mitelman (CGAP)Pineal bodyCombined germ cell tumors  
13 Mitelman-13  Mitelman (CGAP)Pineal bodyPrimitive neuroectodermal tumor/Medulloblastoma  
13 Mitelman-13  Mitelman (CGAP)PituitaryAdenoma  
13 Mitelman+13  Mitelman (CGAP)PituitaryAdenoma  
13 Mitelman-13  Mitelman (CGAP) Plasma cell leukemia  
13 Mitelman+13  Mitelman (CGAP) Plasma cell leukemia  
13 Mitelman-13  Mitelman (CGAP)PleuraMesothelioma  
13 Mitelman-13  Mitelman (CGAP) Polycythemia vera  
13 Mitelman-13  Mitelman (CGAP) Primary effusion lymphoma  
13 Mitelman-13  Mitelman (CGAP)ProstateAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)ProstateAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP) Refractory anemia  
13 Mitelman+13  Mitelman (CGAP) Refractory anemia  
13 Mitelman-13  Mitelman (CGAP) Refractory anemia with excess blasts-1  
13 Mitelman-13  Mitelman (CGAP) Refractory anemia with excess blasts-2  
13 Mitelman+13  Mitelman (CGAP) Refractory anemia with excess blasts-2  
13 Mitelman-13  Mitelman (CGAP) Refractory anemia with excess of blasts (FAB)  
13 Mitelman+13  Mitelman (CGAP) Refractory anemia with excess of blasts (FAB)  
13 Mitelman-13  Mitelman (CGAP) Refractory anemia with ringed sideroblasts  
13 Mitelman-13  Mitelman (CGAP) Refractory cytopenia with multilineage dysplasia  
13 Mitelman+13  Mitelman (CGAP) Refractory cytopenia with multilineage dysplasia  
13 Mitelman-13  Mitelman (CGAP)Salivary glandAdenoma  
13 Mitelman-13  Mitelman (CGAP)SkeletonChondroma  
13 Mitelman-13  Mitelman (CGAP)SkeletonChondrosarcoma, clear cell  
13 Mitelman-13  Mitelman (CGAP)SkeletonChondrosarcoma, dedifferentiated  
13 Mitelman-13  Mitelman (CGAP)SkeletonChondrosarcoma, myxoid  
13 Mitelman-13  Mitelman (CGAP)SkeletonChondrosarcoma, NOS  
13 Mitelman+13  Mitelman (CGAP)SkeletonChondrosarcoma, NOS  
13 Mitelman-13  Mitelman (CGAP)SkeletonChordoma  
13 Mitelman-13  Mitelman (CGAP)SkeletonEwing sarcoma  
13 Mitelman+13  Mitelman (CGAP)SkeletonEwing sarcoma  
13 Mitelman-13  Mitelman (CGAP)SkeletonGiant cell tumor of bone  
13 Mitelman-13  Mitelman (CGAP)SkeletonOsteoblastoma  
13 Mitelman-13  Mitelman (CGAP)SkeletonOsteosarcoma, NOS  
13 Mitelman+13  Mitelman (CGAP)SkeletonOsteosarcoma, NOS  
13 Mitelman-13  Mitelman (CGAP)SkeletonOsteosarcoma, telangiectatic  
13 Mitelman-13  Mitelman (CGAP)SkinBasal cell carcinoma  
13 Mitelman+13  Mitelman (CGAP)SkinBasal cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)SkinMalignant melanoma  
13 Mitelman+13  Mitelman (CGAP)SkinMalignant melanoma  
13 Mitelman-13  Mitelman (CGAP)SkinMerkel cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)SkinSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)Small intestineGastrointestinal stromal tumor  
13 Mitelman-13  Mitelman (CGAP)Small intestineLeiomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueAdipocytic tumor, special type  
13 Mitelman-13  Mitelman (CGAP)Soft tissueAlveolar rhabdomyosarcoma  
13 Mitelman+13  Mitelman (CGAP)Soft tissueAlveolar rhabdomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueAngiosarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueAtypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueChondroma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueDermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma  
13 Mitelman+13  Mitelman (CGAP)Soft tissueDermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueDesmoid-type fibromatosis  
13 Mitelman-13  Mitelman (CGAP)Soft tissueEmbryonal rhabdomyosarcoma  
13 Mitelman+13  Mitelman (CGAP)Soft tissueEmbryonal rhabdomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueEpithelioid sarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueFibroblastic/myofibroblastic tumor, NOS  
13 Mitelman-13  Mitelman (CGAP)Soft tissueInflammatory myofibroblastic tumor/myofibroblastic sarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueLeiomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueLipoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueLiposarcoma, dedifferentiated  
13 Mitelman-13  Mitelman (CGAP)Soft tissueLiposarcoma, myxoid/round cell  
13 Mitelman+13  Mitelman (CGAP)Soft tissueLiposarcoma, myxoid/round cell  
13 Mitelman-13  Mitelman (CGAP)Soft tissueLiposarcoma, pleomorphic  
13 Mitelman-13  Mitelman (CGAP)Soft tissueMalignant peripheral nerve sheath tumor/Triton  
13 Mitelman+13  Mitelman (CGAP)Soft tissueMalignant peripheral nerve sheath tumor/Triton  
13 Mitelman-13  Mitelman (CGAP)Soft tissueMyoepithelioma/myoepithelial carcinoma/mixed tumor  
13 Mitelman-13  Mitelman (CGAP)Soft tissueMyogenic sarcoma, NOS  
13 Mitelman-13  Mitelman (CGAP)Soft tissueMyxofibrosarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueMyxoinflammatory fibroblastic sarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissuePleomorphic rhabdomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueRhabdomyosarcoma, NOS  
13 Mitelman-13  Mitelman (CGAP)Soft tissueSclerosing epithelioid fibrosarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueSoft tissue tumor, NOS  
13 Mitelman-13  Mitelman (CGAP)Soft tissueSoft tissue tumor, special type  
13 Mitelman-13  Mitelman (CGAP)Soft tissueSolitary fibrous tumor  
13 Mitelman-13  Mitelman (CGAP)Soft tissueSpindle cell/pleomorphic lipoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueSynovial sarcoma  
13 Mitelman+13  Mitelman (CGAP)Soft tissueSynovial sarcoma  
13 Mitelman-13  Mitelman (CGAP)Soft tissueUndifferentiated pleomorphic sarcoma  
13 Mitelman+13  Mitelman (CGAP)Soft tissueUndifferentiated pleomorphic sarcoma  
13 Mitelman+13  Mitelman (CGAP)Spinal cordEpendymoma  
13 Mitelman-13  Mitelman (CGAP)Spinal cordMeningioma  
13 Mitelman-13  Mitelman (CGAP) Splenic marginal zone B-cell lymphoma  
13 Mitelman+13  Mitelman (CGAP) Splenic marginal zone B-cell lymphoma  
13 Mitelman-13  Mitelman (CGAP)StomachAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)StomachAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)StomachLeiomyosarcoma  
13 Mitelman-13  Mitelman (CGAP) T-cell granular lymphocytic leukemia  
13 Mitelman-13  Mitelman (CGAP)TestisCombined germ cell tumors  
13 Mitelman+13  Mitelman (CGAP)TestisCombined germ cell tumors  
13 Mitelman-13  Mitelman (CGAP)TestisDiffuse large B-cell lymphoma  
13 Mitelman-13  Mitelman (CGAP)TestisSeminoma/Dysgerminoma  
13 Mitelman+13  Mitelman (CGAP)TestisSeminoma/Dysgerminoma  
13 Mitelman-13  Mitelman (CGAP)TestisTeratoma (mature and immature)  
13 Mitelman+13  Mitelman (CGAP)TestisTeratoma (mature and immature)  
13 Mitelman-13  Mitelman (CGAP)ThyroidAdenocarcinoma  
13 Mitelman+13  Mitelman (CGAP)ThyroidAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)ThyroidAdenoma  
13 Mitelman+13  Mitelman (CGAP)ThyroidAdenoma  
13 Mitelman-13  Mitelman (CGAP)ThyroidNonneoplastic epithelial disorder/lesion  
13 Mitelman-13  Mitelman (CGAP)ThyroidUndifferentiated carcinoma  
13 Mitelman-13  Mitelman (CGAP)TongueSquamous cell carcinoma  
13 Mitelman+13  Mitelman (CGAP)TongueSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP) T-prolymphocytic leukemia  
13 Mitelman+13  Mitelman (CGAP) T-prolymphocytic leukemia  
13 Mitelman-13  Mitelman (CGAP)Unknown siteMalignant melanoma  
13 Mitelman+13  Mitelman (CGAP)Unknown siteMalignant melanoma  
13 Mitelman-13  Mitelman (CGAP)Unknown siteNeuroblastoma  
13 Mitelman-13  Mitelman (CGAP)Unknown siteOsteosarcoma, NOS  
13 Mitelman-13  Mitelman (CGAP)Uterus, cervixAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)Uterus, cervixCarcinoma, NOS  
13 Mitelman-13  Mitelman (CGAP)Uterus, cervixSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP)Uterus, corpusAdenocarcinoma  
13 Mitelman-13  Mitelman (CGAP)Uterus, corpusEndometrial stromal sarcoma  
13 Mitelman+13  Mitelman (CGAP)Uterus, corpusEndometrial stromal sarcoma  
13 Mitelman-13  Mitelman (CGAP)Uterus, corpusLeiomyoma  
13 Mitelman+13  Mitelman (CGAP)Uterus, corpusMetaplastic carcinoma  
13 Mitelman+13  Mitelman (CGAP)VaginaEmbryonal rhabdomyosarcoma  
13 Mitelman-13  Mitelman (CGAP)VaginaSquamous cell carcinoma  
13 Mitelman+13  Mitelman (CGAP)VaginaSquamous cell carcinoma  
13 Mitelman-13  Mitelman (CGAP) Waldenström macroglobulinemia  
[ Bold normal : A; Italic normal :G; Italic small : E ]

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 [previous]   13 13p 13q 13p13 13p12 13p11 13q11 13q12 13q13 13q14 13q21 13q22 13q31 13q32 13q33 13q34   [next]

References

  • [L] Fusion gene microarray reveals cancer type-specificity among fusion genes. Lovf M et al.Genes Chromosomes Cancer. 2011 May;50(5):348-57.   [PubMed 2011]
  • [S] A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis. Skotheim RI, et al. Mol Cancer. 2009 Jan 19;8:5.  [PubMed 21009]
  • [V] ETV6 fusion genes in hematological malignancies: A review. De Braekeleer E. et al. Leuk Res. 2012 May 12.   [PubMed 2012]
  • [GT] Cell Lines (Genentech)  [Pubmed 2015]   Nature Biotech Suppl.Table8
  • [FC] Fusion cancer (Beijing) [PubMed 2015] (the fusions are limited to class A and B)
  • [NOR] [PubMed 2016] Babiceanu M et al. Recurrent chimeric fusion RNAs in non-cancer tissues and cells. Nucleic Acids Res. 2016 Feb 2 (Table S3)
  • [URK][PubMed 2016] Urakami et al. Next generation sequencing approach for detecting 491 fusion genes from human cancer. Biomed Res. 2016;37(1):51-62.
  • [AM] [PubMed 2016] Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancersAlaei-Mahabadi B. et al.,Proc Natl Acad Sci U S A. 2016 Nov 16. pii: 201606220.
  • [FM] [PubMed 2018] Genomic hotspots but few recurrent fusion genes in breast cancer, Fimereli et al., Genes Chromosomes Cancer. (SupplTableS2.xls) 2018 Feb 13
  • [MA] [PubMed 2018] Pan-cancer genome and transcriptome analyses of1,699 paediatric leukaemias and solid tumours, Ma et al, Nature (March 2018) Table S3
  • [GAO] [PubMed 2018] Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Gao et al, Cell Reports (April 2018) Table S2
  • [MAY] [PubMed 2018] Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in Tumor, Winters et al (July 2018) Table S7
  • FusionGDB: fusion gene annotation DataBase. Kim P t Zhou X. Nucleic Acids Res. 2019 Jan 8;47(D1):D994-D1004.[PubMed]site FusionGDB

    Contributor(s)

    Writtenmay 2012Philippe Dessen
      
    Updatedjanv. 2019Philippe Dessen and Jean-Loup Huret

    Citation

    This paper should be referenced as such :
    Dessen P and Huret JL. Chromosomal band 13. Atlas Genet Cytogenet Oncol Haematol. July 2012.
    URL : https://atlasgeneticsoncology.usal.es/classic/Bands/13.html
    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : mar. janv. 22 11:51:34 CET 2019

    Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching